Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer.
To predict the response of breast cancer patients to neoadjuvant chemotherapy (NAC) using features derived from dynamic contrast-enhanced (DCE) MRI.
Author(s): Golden, Daniel I, Lipson, Jafi A, Telli, Melinda L, Ford, James M, Rubin, Daniel L
DOI: 10.1136/amiajnl-2012-001460